Heather Han

Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2.

Rita Nanda, Minetta C. Liu, Christina Yau et al. · Journal of Clinical Oncology · 2017 · 208 citations

Breast Oncology, High-risk Breast Cancer, Immunology +21

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

Heather Han, Véronique Dièras, Mark E. Robson et al. · Annals of Oncology · 2017 · 201 citations · Full text

Carboplatin/paclitaxel Versus Placebo, Breast Oncology, Recurrent/metastatic Breast Cancer +9

Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters

Richard R. Reich, Cecile A. Lengacher, Carissa B. Alinat et al. · Journal of Pain and Symptom Management · 2016 · 192 citations · Full text

Psychiatry, Meditation, Mindfulness-based Stress Reduction +9

Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience

Nicholas Figura, Wendy Long, Michael Yu et al. · Breast Cancer Research and Treatment · 2018 · 36 citations

Single Institution Experience, Intrathecal Trastuzumab, Gynecology +4

Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer

Véronique Dièras, Heather Han, Bella Kaufman et al. · Annals of Oncology · 2019 · 32 citations · Full text

Breast Oncology, Oncology, Medicine +7